Natixis »

Dyne Therapeutics shares owned by Natixis

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Natixis

Quarter filed Position value Share count Share price at filing
2024-03-31 $398k 14k 28.39

More positions owned by Natixis

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Coinbase Global Com Cl A (COIN)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Broadcom (AVGO)
Select Sector Spdr Tr Indl (XLI)
Energy Transfer Com Ut Ltd Ptn (ET)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Cisco Systems (CSCO)
Meta Platforms Cl A (META)

View all positions for Natixis

Top funds holding Dyne Therapeutics

Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
BlackRock
RA Capital Management
Citadel Advisors
MPM Asset Management
Vanguard Group
FMR
Henderson Group
Adage Capital Partners GP
VR Adviser
Sofinnova Ventures
Franklin Resources
Logos Global Management
Goldman Sachs Group

View all funds holding Dyne Therapeutics